Of the 12 genomic DNA tumor samples from our cohort, 9 were from patients who had no mutation on AIP sequencing of the peripheral blood DNA (6 somatotropinomas, 2 prolactinomas and 1 Cushing’s disease). This evidence concerns the gene AIP and growth hormone-producing pituitary gland neoplasm.